As we pack up the stand after four fascinating days at the European Cancer Congress 2015, I have a little time to reflect on some of the conversations we have had on industry’s move to disclose publicly payments to health professionals.
The first observation is that despite the first disclosures being scheduled for the second quarter of 2016, there are still many individuals in the medical community and even some in the industry that are not yet aware of this transformational step in the relationship between industry and the health professionals we work with. We had a number of conversations with delegates that were hearing about disclosure for the first time. As an industry, and particularly from the EFPIA perspective, we will continue our focus on providing information about the rationale, process and implications of disclosure. We are providing more and more information online that can be accessed at www.efpia.eu/disclosure and you can follow the latest news and updates on disclosure through social media by following #pharmadisclosure
To read the article by Andrew Powrie-Smith, EFPIA Communications Director